Cancer Treatment Foundation: Estonian Health Insurance Fund takes over funding of six anticancer drugs from donors

Since 1 January the Estonian Health Insurance Fund has been compensating six modern anticancer drugs, which people previously had to purchase relying on the help of the Cancer Treatment Foundation and other charitable funds.


The medicines are for the treatment of lung, bone marrow, stomach, oesophageal and kidney tumours, lymphoma and leukaemia. According to the Health Insurance Fund, around 200 people per year require these specific medicines.


"We welcome the fact that these treatments, which to date people have had to rely on the help of donors in order to buy, are now being covered under state health insurance,” said Toivo Tänavsuu, the head of the cancer treatment foundation ‘The Gift of Life’. “Four out of six drugs are known to us here at the foundation. Over time we’ve purchased these medications for many people, thereby helping them to escape the abyss that the non-funding of the drugs would otherwise have left them in."


The following anti-cancer medicines have been compensated by the Health Insurance Fund since the start of the year:

- DARZALEX: for the treatment of multiple myeloma in adult patients

- KEYTRUDA: for metastatic non-small cell lung cancer patients and patients with Hodgkin's lymphoma. The fund has helped many patients with different diagnoses obtain this medication. Some of them are now getting treatment at the cost of the Health Insurance Fund; others continue to have to rely on the support of the Cancer Treatment Foundation.

- ZYKADIA: for patients with metastatic non-small cell lung cancer

- XTANDI: for the treatment of metastatic prostate cancer. This medicine has been known to the foundation since 2015.

- QARZIBA: for the treatment of high-risk neuroblastoma. This is the medication which 8-year-old Annabel and 6-year-old Tauris obtained with the support of the fund, both of whom were declared free from the disease in spring 2018. ‘The Gift of Life’ and the Estonian Association of Parents of Children with Cancer, the organiser of the charity Duck Rally, contributed almost 250,000 euros to the treatment of the two children.

- BLINCYTO: for patients with lymphoblastic leukaemia. 35-year-old mother Maily was able to obtain this exorbitantly priced drug with the help of the fund in early 2018, but sadly succumbed to her illness.


By the end of 2020, the foundation will have ‘supported’ the Estonian government with almost a million euros
This year, the foundation is running at a deficit of 150,000 euros - which is almost equal to how much the government has profited from us! 
13.07.2020
Fortunately there is a cancer treatment foundation
Every day the foundation receives at least one new application for assistance; some days several. Over the last week the number of people receiving assistance from the foundation has grown significantly. 
23.06.2020
Young mother: "Thanks to donations to the Gift of Life, I can make unforgettable memories with my children"
We have been supporting 38-year-old Mari, who lives just outside of Tallinn, in her battle with stomach cancer since the beginning of January
07.05.2020